96 related articles for article (PubMed ID: 34403115)
1. RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.
Roundhill EA; Chicon-Bosch M; Jeys L; Parry M; Rankin KS; Droop A; Burchill SA
Cell Oncol (Dordr); 2021 Oct; 44(5):1065-1085. PubMed ID: 34403115
[TBL] [Abstract][Full Text] [Related]
2. Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients.
Sannino G; Marchetto A; Ranft A; Jabar S; Zacherl C; Alba-Rubio R; Stein S; Wehweck FS; Kiran MM; Hölting TLB; Musa J; Romero-Pérez L; Cidre-Aranaz F; Knott MML; Li J; Jürgens H; Sastre A; Alonso J; Da Silveira W; Hardiman G; Gerke JS; Orth MF; Hartmann W; Kirchner T; Ohmura S; Dirksen U; Grünewald TGP
EBioMedicine; 2019 Sep; 47():156-162. PubMed ID: 31427232
[TBL] [Abstract][Full Text] [Related]
3. [The expression of neuraminidase-1 in Ewing sarcoma and its impact on sarcoma cell proliferation and migration].
Liu BF; Gao YZ
Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3287-3293. PubMed ID: 37926573
[No Abstract] [Full Text] [Related]
4. Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease.
Potratz J; Tillmanns A; Berning P; Korsching E; Schaefer C; Lechtape B; Schleithoff C; Unland R; Schäfer KL; Müller-Tidow C; Jürgens H; Dirksen U
Mol Oncol; 2016 May; 10(5):677-92. PubMed ID: 26739507
[TBL] [Abstract][Full Text] [Related]
5. Soft Tissue Ewing Sarcoma Cell Drug Resistance Revisited: A Systems Biology Approach.
Asfa S; Toy HI; Arshinchi Bonab R; Chrousos GP; Pavlopoulou A; Geronikolou SA
Int J Environ Res Public Health; 2023 Jul; 20(13):. PubMed ID: 37444135
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of PRR11 and immune cell infiltration in Ewing sarcoma.
Wen J; Wan L; Dong X
PLoS One; 2024; 19(3):e0299720. PubMed ID: 38427643
[TBL] [Abstract][Full Text] [Related]
7. Integrative analyses of bulk microarray data to discover genes, pathways, and immune infiltration characteristics associated with targeting of Ewing sarcoma.
Cao B; Sun H; Fan Z; Khawar MB; Cai L; Yu S; Liang Z; Lv D; Wang N; Bi C; Sun H
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6967-6977. PubMed ID: 36849756
[TBL] [Abstract][Full Text] [Related]
8. Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma.
Mooney B; Negri GL; Shyp T; Delaidelli A; Zhang HF; Spencer Miko SE; Weiner AK; Radaoui AB; Shraim R; Lizardo MM; Hughes CS; Li A; El-Naggar AM; Rouleau M; Li W; Dimitrov DS; Kurmasheva RT; Houghton PJ; Diskin SJ; Maris JM; Morin GB; Sorensen PH
Clin Cancer Res; 2024 Mar; 30(5):1022-1037. PubMed ID: 37812652
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma.
Tan K; Lu W; Chen F; Shi H; Ma Y; Chen Z; Wu W; Lv Z; Mo J
J Exp Clin Cancer Res; 2023 Sep; 42(1):250. PubMed ID: 37759224
[TBL] [Abstract][Full Text] [Related]
10. Structures of neurexophilin-neurexin complexes reveal a regulatory mechanism of alternative splicing.
Wilson SC; White KI; Zhou Q; Pfuetzner RA; Choi UB; Südhof TC; Brunger AT
EMBO J; 2019 Nov; 38(22):e101603. PubMed ID: 31566781
[TBL] [Abstract][Full Text] [Related]
11. Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma.
Cidre-Aranaz F; Li J; Hölting TLB; Orth MF; Imle R; Kutschmann S; Ammirati G; Ceranski K; Carreño-Gonzalez MJ; Kasan M; Marchetto A; Funk CM; Bestvater F; Bersini S; Arrigoni C; Moretti M; Thiel U; Baumhoer D; Sahm F; Pfister SM; Hartmann W; Dirksen U; Romero-Pérez L; Banito A; Ohmura S; Musa J; Kirchner T; Knott MML; Grünewald TGP
Mol Cancer; 2022 Jan; 21(1):1. PubMed ID: 34980141
[No Abstract] [Full Text] [Related]
12. First-line Anti-GD2 Therapy Combined With Consolidation Chemotherapy in 3 Patients With Newly Diagnosed Metastatic Ewing Sarcoma or Ewing-like Sarcoma.
Spasov NJ; Dombrowski F; Lode HN; Spasova M; Ivanova L; Mumdjiev I; Burnusuzov H; Siebert N
J Pediatr Hematol Oncol; 2022 Aug; 44(6):e948-e953. PubMed ID: 35622995
[TBL] [Abstract][Full Text] [Related]
13. Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting Cells.
Visser LL; Bleijs M; Margaritis T; van de Wetering M; Holstege FCP; Clevers H
Cancer Res Commun; 2023 Oct; 3(10):2158-2169. PubMed ID: 37823774
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability.
Balaraman K; Deniz E; Nelson E; Pilicer SL; Atasoy S; Molotkova A; Sevim H; Tiwari PB; Üren A; Wolf C
Eur J Med Chem; 2023 May; 251():115244. PubMed ID: 36917882
[TBL] [Abstract][Full Text] [Related]
15. miRNA signatures in childhood sarcomas and their clinical implications.
Viera GM; Salomao KB; de Sousa GR; Baroni M; Delsin LEA; Pezuk JA; Brassesco MS
Clin Transl Oncol; 2019 Dec; 21(12):1583-1623. PubMed ID: 30949930
[TBL] [Abstract][Full Text] [Related]
16. Dualistic Effects of PRKAR1A as a Potential Anticancer Target in Cancer Cells and Cancer-Derived Stem Cells.
Baek JW; Nam AR; Kim K; Kim PH
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474121
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cell biomarkers and related signalling pathways.
Wang Z; Li R; Yang G; Wang Y
J Drug Target; 2024 Dec; 32(1):33-44. PubMed ID: 38095181
[TBL] [Abstract][Full Text] [Related]
18. Stemness and Cell Cycle Regulators and Their Modulation by Retinoic Acid in Ewing Sarcoma.
Battistella ME; Freire NH; Toson B; Dalmolin M; Fernandes MAC; Tassinari ID; Jaeger M; Brunetto AT; Brunetto AL; Gregianin L; de Farias CB; Roesler R
Curr Issues Mol Biol; 2024 Apr; 46(5):3990-4003. PubMed ID: 38785514
[TBL] [Abstract][Full Text] [Related]
19. Identification of ARAP3 as a regulator of tumor progression, macrophage infiltration and osteoclast differentiation in a tumor microenvironment-related prognostic model of Ewing sarcoma.
Wang Y; Jiang R; Wang T; Wu Z; Gong H; Cai X; Liu J; Yang X; Wei H; Jiao J; Jia Q; Yang C; Zhao C; Xiao J
Am J Cancer Res; 2023; 13(8):3721-3740. PubMed ID: 37693165
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of
Wen J; Yi L; Wan L; Dong X
Heliyon; 2023 Sep; 9(9):e19357. PubMed ID: 37662777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
